A new treatment for the deadly children's cancer neuroblastoma dramatically improves survival and has become part of the standard course of care even before results were published.

The study by researchers at Children's Hospital of Philadelphia and other top pediatric hospitals represents the first major improvement in survival for high-risk neuroblastoma in more than a decade, and the techniques involved might be adapted to other cancers such as melanoma... Read More